1 |
Yang L, Zheng RS, Wang N, et al. Analysis of Incidence and Mortality of Thyroid Cancer in China, 2013 [J]. Zhonghua Zhong Liu Za Zhi, 2017, 39(11): 862-867.
|
2 |
Olson E, Wintheiser G, Wolfe KM, et al. Epidemiology of Thyroid Cancer: A Review of the National Cancer Database, 2000-2013 [J]. Cureus, 2019, 11(2): e4127.
|
3 |
Kuşcu O, Önay Ö, Kayahan B, et al. The rising incidence of papillary thyroid microcarcinoma and is completion surgery necessary or not? [J]. Otolaryngol Pol, 2016, 70(3): 14-18.
|
4 |
Leboulleux S, Tuttle RM, Pacini F, et al. Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? [J]. Lancet Diabetes Endocrinol, 2016, 4(11): 933-942.
|
5 |
Brito JP, Hay ID. Management of Papillary Thyroid Microcarcinoma [J]. Endocrinol Metab Clin North Am, 2019, 48(1): 199-213.
|
6 |
Miyauchi A, Ito Y. Conservative Surveillance Management of Low-Risk Papillary Thyroid Microcarcinoma [J]. Endocrinol Metab Clin North Am, 2019, 48(1): 215-226.
|
7 |
Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation [J]. Thyroid, 2014, 24(1): 27-34.
|
8 |
Yu XM, Wan Y, Sippel RS, et al. Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases [J]. Ann Surg, 2011, 254(4): 653-660.
|
9 |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer [J]. Thyroid, 2016, 26(1): 1-133.
|
10 |
Zhang M, Luo Y, Zhang Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study [J]. Thyroid, 2016, 26(11): 1581-1587.
|
11 |
Teng D, Sui G, Liu C, et al. Long-term efficacy of ultrasound-guided low power microwave ablation for the treatment of primary papillary thyroid microcarcinoma: a 3-year follow-up study [J]. J Cancer Res Clin Oncol, 2018, 144(4): 771-779.
|
12 |
Kim JH, Baek JH, Sung JY, et al. Radiofrequency ablation of low-risk small papillary thyroidcarcinoma: preliminary results for patients ineligible for surgery [J]. Int J Hyperthermia, 2017, 33(2): 212-219.
|
13 |
Papini E, Guglielmi R, Gharib H, et al. Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk [J]. Thyroid, 2011, 21(8): 917-920.
|
14 |
Valcavi R, Piana S, Bortolan GS, et al. Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma: a feasibility study on three cases with pathological and immunohistochemical evaluation [J]. Thyroid, 2013, 23(12): 1578-1582.
|
15 |
Yue W, Wang S, Yu S, et al. Ultrasound-guided percutaneous microwave ablation of solitary T1N0M0 papillary thyroid microcarcinoma: initial experience [J]. Int J Hyperthermia, 2014, 30(2): 150-157.
|
16 |
Lim HK, Baek SM, Baek JH. Us-guided RFA for primary thyroid cancer: efficacy and safety of long-term follow-up in a large population [C]//CIRSE (Cardiovascular and Interventional Radiological Society of Europe), Copenhagen, 2017.
|
17 |
中华医学会内分泌学分会, 中华医学会外科学分会,中国抗癌协会头颈肿瘤专业委员会. 甲状腺结节和分化型甲状腺癌诊治指南 [J]. 中国肿瘤临床, 2012, 39(17): 1249-1268.
|
18 |
Tessler FN, Middleton WD, Grant EG, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee [J]. J Am Coll Radiol, 2017, 14(5): 587-595.
|
19 |
中国医师协会超声医师分会. 中国超声造影临床应用指南 [M]. 北京: 人民卫生出版社, 2017: 19-22.
|
20 |
Sidhu PS, Cantisani V, Dietrich CF, et al. The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Short Version) [J]. Ultraschall Med, 2018, 39(2): 154-180.
|
21 |
Lee YH, Baek JH, Jung SL, et al. Ultrasound-Guided Fine Needle Aspiration of Thyroid Nodules: A Consensus Statement by the Korean Society of Thyroid Radiology [J]. Korean J Radiol, 2015, 16(2): 391-401.
|
22 |
Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology [J]. Thyroid, 2017, 27(11): 1341-1346.
|
23 |
Rodrigues AC, Penna G, Rodrigues E, et al. The Genetics of Papillary Microcarcinomas of the Thyroid: Diagnostic and Prognostic Implications [J]. Curr Genomics, 2017, 18(3): 244-254.
|
24 |
Nikiforova MN, Mercurio S, Wald AI, et al. Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules [J]. Cancer, 2018, 124(8): 1682-1690.
|